Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Sarcoma 1Genitourinary 1Breast 1

Conditions

Prostatic Neoplasms 1Osteosarcoma 1Neoplasms 1Breast Neoplasms 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Tissue and Organ Procurement × Clear all
NCT00580385 2026-05-01

Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase NA Active not recruiting
763 enrolled
Sarcoma

Osteosarcoma

NCT04060589 2023-03-22

ReIMAGINE Prostate Cancer Risk

University College, London

Unknown
1,000 enrolled
Genitourinary

Prostatic Neoplasms

NCT03300102 2019-01-24

Tumouroids

University College, London

Completed
19 enrolled
Tumor-Agnostic

Neoplasms

NCT00161265 2016-07-29

Tissue Procurement Protocol for Patients Undergoing Neoadjuvant Systemic Therapy for Breast Cancer

University of Michigan Rogel Cancer Center

Completed
68 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡